Literature DB >> 21675962

Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model.

Sandra Villanueva1, Ernesto Ewertz, Flavio Carrión, Andrés Tapia, César Vergara, Carlos Céspedes, Pablo J Sáez, Patricia Luz, Carlos Irarrázabal, Juan E Carreño, Fernando Figueroa, Carlos P Vio.   

Abstract

CKD (chronic kidney disease) has become a public health problem. The therapeutic approaches have been able to reduce proteinuria, but have not been successful in limiting disease progression. In this setting, cell therapies associated with regenerative effects are attracting increasing interest. We evaluated the effect of MSC (mesenchymal stem cells) on the progression of CKD and the expression of molecular biomarkers associated with regenerative effects. Adult male Sprague-Dawley rats subjected to 5/6 NPX (nephrectomy) received a single intravenous infusion of 0.5×106 MSC or culture medium. A sham group subjected to the same injection was used as the control. Rats were killed 5 weeks after MSC infusion. Dye tracking of MSC was followed by immunofluorescence analysis. Kidney function was evaluated using plasma creatinine. Structural damage was evaluated by H&E (haematoxylin and eosin) staining, ED-1 abundance (macrophages) and interstitial α-SMA (α-smooth muscle actin). Repairing processes were evaluated by functional and structural analyses and angiogenic/epitheliogenic protein expression. MSC could be detected in kidney tissues from NPX animals treated with intravenous cell infusion. This group presented a marked reduction in plasma creatinine levels and damage markers ED-1 and α-SMA (P<0.05). In addition, treated rats exhibited a significant induction in epitheliogenic [Pax-2, bFGF (basic fibroblast growth factor) and BMP-7 (bone morphogenetic protein-7)] and angiogenic [VEGF (vascular endothelial growth factor) and Tie-2] proteins. The expression of these biomarkers of regeneration was significantly related to the increase in renal function. Many aspects of the cell therapy in CKD remain to be investigated in more detail: for example, its safety, low cost and the possible need for repeated cell injections over time. Beyond the undeniable importance of these issues, what still needs to be clarified is whether MSC administration has a real effect on the treatment of this pathology. It is precisely to this point that the present study aims to contribute.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21675962     DOI: 10.1042/CS20110108

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  29 in total

Review 1.  Renal organogenesis: what can it tell us about renal repair and regeneration?

Authors:  Melissa H Little
Journal:  Organogenesis       Date:  2011 Oct-Dec       Impact factor: 2.500

2.  Injection of amniotic fluid stem cells delays progression of renal fibrosis.

Authors:  Sargis Sedrakyan; Stefano Da Sacco; Anna Milanesi; Liron Shiri; Astgik Petrosyan; Radka Varimezova; David Warburton; Kevin V Lemley; Roger E De Filippo; Laura Perin
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

3.  Bioengineered kidneys: new sights on a distant horizon.

Authors:  Christoph Kuppe; Katja Berger; Bart Smeets
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

Review 4.  Concise review: different mesenchymal stromal/stem cell populations reside in the adult kidney.

Authors:  Stefania Bruno; Giulia Chiabotto; Giovanni Camussi
Journal:  Stem Cells Transl Med       Date:  2014-10-29       Impact factor: 6.940

5.  Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.

Authors:  Fei Gu; Dandan Wang; Huayong Zhang; Xuebing Feng; Gary S Gilkeson; Songtao Shi; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-08-14       Impact factor: 2.980

6.  Does the greater omentum ("policeman of the abdomen") possess therapeutic utility in CKD?

Authors:  Christof Westenfelder
Journal:  J Am Soc Nephrol       Date:  2014-03-13       Impact factor: 10.121

7.  Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients.

Authors:  Milica Bozic; Angels Betriu; Marcelino Bermudez-Lopez; Alberto Ortiz; Elvira Fernandez; Jose M Valdivielso
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 8.237

8.  Efficacy of different hemodialysis methods on dendritic cell marker CD40 and CD80 and platelet activation marker CD62P and P10 in patients with chronic renal failure.

Authors:  Xin-Fang Wang; Bei-Hao Zhang; Xiao-Qing Lu; Pei Wang
Journal:  J Clin Lab Anal       Date:  2018-11-29       Impact factor: 2.352

Review 9.  Update on the treatment of focal segmental glomerulosclerosis in renal transplantation.

Authors:  Maria Messina; Ester Gallo; Alberto Mella; Fabiola Pagani; Luigi Biancone
Journal:  World J Transplant       Date:  2016-03-24

10.  Effect of bone marrow stem cell mobilisation on the expression levels of cellular growth factors in a rat model of acute tubular necrosis.

Authors:  Lingyun Bi; Ruanling Hou; Dasheng Yang; Dean Zhao; Shujun Li; Jingli Zhao; H E Zhang
Journal:  Exp Ther Med       Date:  2015-06-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.